Holista Colltech Ltd has released a press release.
HCT to Co-Develop Nasal Sanitising Balm and Extend NatShield
Filed with ASX ·
6ix hasn’t read this filing yet.
Holista Colltech Limited on 6ix
In the deck
Earlier from Holista Colltech
- Response to ASX Price and Volume Query
- Controlled Placement Agreement & Share Issue
- Increase in shipments for Natshield and Aust bottling plans
- Natshield Nasal Balm with Path-Away as Viruses Barrier
- Appendix 4C Quarterly Report and Quarterly Review
Later from Holista Colltech
- Pause in Trade
- Retraction of Statements and Clarification
- Dr Arthur Martin joins Scientific Advisory Board
- Letter of confirmation towards global distribution rights
- Maiden Sales of $1.4M for 80Less Sugar Formulation
Follow Holista Colltech into a list and get an email when it puts out news.
Follow Holista Colltech